Corpus Intelligence IC Memo — SSH - OKLAHOMA CITY INC. 2026-04-26 05:20 UTC
IC Memo — SSH - OKLAHOMA CITY INC.
Investment Committee Memorandum | OK | 72 beds | Grade D | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - OKLAHOMA CITY INC.

CCN 372009 | OKLAHOMA, OK | 72 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SSH - OKLAHOMA CITY INC. is a 72-bed suburban community hospital in OKLAHOMA, OK with $48.8M in net patient revenue and a 9.9% operating margin. The hospital serves a payer mix of 53.7% Medicare, 0.6% Medicaid, and 45.7% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.9% to 17.3% (+736bps).

Net Revenue HCRIS$48.8M
Current EBITDA COMPUTED$4.8M
Operating Margin COMPUTED9.9%
Occupancy HCRIS92.3%
Revenue / Bed COMPUTED$678K
Net-to-Gross HCRIS16.8%
Distress Probability ML38.0%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
60
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 9.9% places it above the state median. Among 60 size-comparable peers (36-144 beds), the median margin is -4.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-144), prioritizing same-state peers. 60 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - OKLAHOMA CITY INC. (Target)OK72$48.8M9.9%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
OKLAHOMA SURGICAL HOSPITALOK74$146.2M17.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$976K+200bp12mo
Denial Rate Reduction12.0%6.5%$966K+198bp12mo
A/R Days Reduction5200.0%3800.0%$594K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$976K
Denial Rate Reduction
$966K
A/R Days Reduction
$594K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.6M
Current EBITDA$4.8M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$8.4M
Current Margin9.9%
Pro Forma Margin17.3%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.4M$67.8M9.11x55.6%
Base (11x exit)10.0x11.0x$7.4M$77.0M10.34x59.6%
Bull Case9.0x11.0x$6.7M$91.3M13.62x68.6%
Bull (12x exit)9.0x12.0x$6.7M$101.6M15.16x72.2%
Bear Case11.0x10.0x$8.2M$47.5M5.79x42.1%
Bear (11x exit)11.0x11.0x$8.2M$54.9M6.70x46.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 60 hospitals with 36-144 beds
  • Same-state prioritization (n=61)
  • Comp margins: P25=-18.1% / P50=-4.3% / P75=5.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.